Assignee
ALLEGHENY SINGER RES INSTITUTE
US·12 granted patents·5 pending applications·11 citations·filing 2013–2024
Top patents by PatentIndex Score
17 records- 0188US12503594B2Hydrophilic polyarylene ether ketone polymer and methods of forming sameALLEGHENY SINGER RES INSTITUTE·Filed 2024·Granted Dec 23, 2025·0 cites·17 claims
- 0288US11999848B2Hydrophilic polyarylene ether ketone polymer and methods of forming sameALLEGHENY SINGER RES INSTITUTE·Filed 2019·Granted Jun 4, 2024·2 cites·41 claims
- 0388US11763949B1Computer-based tools and techniques for optimizing emergency medical treatmentALLEGHENY SINGER RES INSTITUTE·Filed 2022·Granted Sep 19, 2023·6 cites·26 claims
- 0472US9863946B2Cell-bound complement activation products as diagnostic biomarkers for pre-lupusALLEGHENY-SINGER RES INSTITUTE·Filed 2016·Granted Jan 9, 2018·1 cites·8 claims
- 0571US2026014562A1Devices and methods for separating cells or cell fragmentsALLEGHENY SINGER RES INSTITUTE·Filed 2023·Application pending·0 cites
- 0659US2023094382A1Methods and devices for determining a level of a complement activation productALLEGHENY SINGER RES INSTITUTE·Filed 2022·Application pending·0 cites
- 0755US12433883B2Covalent modification and controlled delivery of mu opioid receptor antagonistsALLEGHENY SINGER RES INSTITUTE·Filed 2020·Granted Oct 7, 2025·0 cites·24 claims
- 0854US9835617B2Isolation of pulmonary arterial endothelial cells from patients with pulmonary vascular disease and uses thereofALLEGHENY-SINGER RES INSTITUTE·Filed 2013·Granted Dec 5, 2017·2 cites·11 claims
- 0953US2023375544A1Methods for Determining a Level of Cell-Bound Complement Activation ProductALLEGHENY SINGER RES INSTITUTE·Filed 2021·Application pending·0 cites
- 1052US2025002551A1Interleukin 7 and interleukin 21 fusion proteinsALLEGHENY SINGER RES INSTITUTE·Filed 2022·Application pending·0 cites
- 1146US11344241B2Conductive fiber with polythiophene coatingALLEGHENY SINGER RES INSTITUTE·Filed 2018·Granted May 31, 2022·0 cites·16 claims
- 1246US11066366B2Hydrophilic fentanyl derivativesALLEGHENY SINGER RES INSTITUTE·Filed 2016·Granted Jul 20, 2021·0 cites·4 claims
- 1346US10481151B2Isolation of pulmonary arterial endothelial cells from patients with pulmonary vascular disease and uses thereofALLEGHENY SINGER RES INSTITUTE·Filed 2017·Granted Nov 19, 2019·0 cites·20 claims
- 1445US2023002727A1Thymus organoids bioengineered from human pluripotent stem cellsALLEGHENY SINGER RES INSTITUTE·Filed 2020·Application pending·0 cites
- 1542US12130288B2Methods and systems using C4 gene copy number and cell-bound complement activation products for identification of lupus and pre-lupusALLEGHENY SINGER RES INSTITUTE·Filed 2017·Granted Oct 29, 2024·0 cites·11 claims
- 1642US11120681B2Method and system for monitoring hand hygiene complianceALLEGHENY SINGER RES INSTITUTE·Filed 2019·Granted Sep 14, 2021·0 cites·18 claims
- 1737US10067128B2Cell-bound complement activation product assays as companion diagnostics for antibody-based drugsALLEGHENY SINGER RES INSTITUTE·Filed 2016·Granted Sep 4, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when ALLEGHENY SINGER RES INSTITUTE files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →